Private company
ThermoGenesis Holdings, Inc.
American laboratory apparatus and furniture company based in Rancho Cordova2
In its 2024 annual report the company says: “ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress® and BioArchive® platforms for automated clinical bio-banking, PXP® platform for point-of-care cell-based therapies and X-Series® products for cell processing services.”4
Last updated Oct 20, 2026.
Overview
- IndustryLaboratory Apparatus & Furniture2
- HeadquartersRancho Cordova, United States2
- Incorporated inDE3
- Business address2890 Kilgore Rd., Rancho Cordova, Ca 956703
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI54930046CTH3DLQ1AR472
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O The Company Corporation, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 20954472
See how the biggest companies compare on our leaderboards
ThermoGenesis Holdings, Inc. (“ThermoGenesis Holdings,” the “Company,” “we,” “our,” “us”) develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. Since the 1990’s, ThermoGenesis Holdings has been a pioneer in, and a leading provider of, automated systems that isolate, purify and cryogenically store units of hematopoietic stem and progenitor cells for the cord blood banking industry. The Company was founded in 1986 and is incorporated in the State of Delaware and headquartered in Rancho Cordova, CA.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue29¢$7.5M
- Research and development5¢$1.3M
- Selling, general and admin28¢$7.2M
- Interest39¢$10.0M
Out of $9.4M in revenue.5 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $14.5M6 | $9.7M7 | $13.0M8 | $9.7M8 | $9.3M9 | $10.5M5 | $9.4M5 |
| Cost of revenue | $8.7M11 | $7.5M7 | $7.4M8 | $8.5M10 | $5.8M9 | $7.8M5 | $7.5M5 |
| Gross profit | $5.8M6 | $2.2M7 | $5.7M8 | $1.3M10 | $3.5M9 | $2.7M5 | $1.9M5 |
| Research and development | $2.5M6 | $3.0M7 | $2.4M8 | $2.5M10 | $2.2M9 | $1.7M5 | $1.3M5 |
| Selling, general and admin | $7.7M10 | $8.5M9 | $7.2M5 | $7.2M5 | |||
| Operating expenses | $10.7M9 | $8.9M5 | $10.5M5 | ||||
| Operating income | -$9.4M6 | -$43.5M7 | -$4.7M8 | -$8.9M10 | -$7.2M9 | -$6.2M5 | -$8.6M5 |
| Interest | $20.5M6 | $2.7M7 | $4.5M8 | $7.9M10 | $6.1M9 | $5.6M5 | $10.0M5 |
| Income tax | -$673.0K6 | -$4.7M7 | $07 | $09 | $09 | ||
| Net income | -$29.1M11 | -$40.9M7 | -$10.1M8 | -$16.8M10 | -$11.9M9 | -$11.8M5 | -$18.9M5 |
| Earnings per share | -$43.419 | -$20.455 | -$7.595 | ||||
| Shares (weighted, basic) | 262.1K shares9 | 551.0K shares5 | 2.4M shares5 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $3.5M6 | $2.4M7 | $3.2M8 | $7.2M10 | $7.3M9 | $4.2M5 | $2.0M5 |
| Receivables | $733.0K9 | $1.9M5 | $949.0K5 | ||||
| Inventory | $5.4M9 | $3.3M5 | $1.4M5 | ||||
| Current assets | $11.5M6 | $8.6M7 | $9.5M8 | $15.3M10 | $15.0M9 | $10.9M5 | $5.2M5 |
| Property, plant and equipment | $1.3M9 | $1.3M5 | $2.6M5 | ||||
| Goodwill | $781.0K5 | $781.0K5 | |||||
| Intangible assets | $1.3M5 | $1.3M5 | |||||
| Total assets | $51.1M6 | $14.6M7 | $15.2M8 | $20.9M10 | $20.7M9 | $19.4M5 | $11.2M5 |
| Accounts payable | $1.3M9 | $820.0K5 | $948.0K5 | ||||
| Current liabilities | $5.5M6 | $6.4M7 | $6.7M8 | $6.1M10 | $6.3M9 | $11.5M5 | $11.8M5 |
| Total liabilities | $17.9M6 | $7.9M7 | $14.3M8 | $15.0M10 | $17.3M9 | $16.1M5 | $14.8M5 |
| Retained earnings | -$264.7M9 | -$266.2M5 | -$284.2M5 | ||||
| Shareholders’ equity | $33.7M6 | $8.4M7 | $386.0K8 | $5.8M10 | $3.8M9 | $4.3M5 | -$1.7M5 |
| Shares outstanding | 10.9M shares6 | 2.2M shares7 | 2.8M shares8 | 8.9M shares10 | 279.6K shares9 | 1.0M shares5 | 3.6M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$7.2M6 | -$7.0M7 | -$3.3M8 | -$14.4M10 | -$6.6M9 | -$7.3M5 | -$3.7M5 |
| Depreciation and amortization | $633.0K9 | $926.0K5 | $1.1M5 | ||||
| Stock-based compensation | $2.6M9 | $267.0K5 | $39.0K5 | ||||
| Capital spending | $375.0K6 | $1.2M7 | $182.0K8 | $23.0K10 | $93.0K9 | $400.0K5 | $1.7M5 |
| Free cash flow | -$7.6M | -$8.2M | -$3.4M | -$14.4M | -$6.7M | -$7.7M | -$5.5M |
| Cash from investing | -$93.0K9 | -$400.0K5 | -$1.7M5 | ||||
| Share buybacks | $134.0K11 | ||||||
| Cash from financing | $6.8M9 | $4.6M5 | $3.3M5 |
Corporate structure
ThermoGenesis Holdings, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of ThermoGenesis Holdings, Inc.
- Boyalife Group, Inc. Filed SC 13D/A on ThermoGenesis Holdings, Inc., latest Nov 28, 2023 (4 filings since Nov 9, 2022)
- Xiaochun Xu Filed SC 13D/A on ThermoGenesis Holdings, Inc., latest Mar 9, 2023
- FOLEY & LARDNER/ FA Filed SC 13D/A on ThermoGenesis Holdings, Inc., latest Feb 16, 2023
- Boyalife Asset Holding II, Inc. Filed SC 13D/A on ThermoGenesis Holdings, Inc., latest Aug 5, 2022 (2 filings since Jul 12, 2022)
- ThermoGenesis Holdings, Inc. Rancho Cordova, California, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What ThermoGenesis Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Construction in progress | $131.0K5 Dec 31, 2023 | $391.0K5 Dec 31, 2022 | −66.5% |
| Property and equipment, before depreciation | $10.2M5 Dec 31, 2023 | $8.4M5 Dec 31, 2022 | +20.5% |
| Accumulated depreciation | $7.6M5 Dec 31, 2023 | $7.2M5 Dec 31, 2022 | +5.6% |
| Property and equipment, net | $2.6M5 Dec 31, 2023 | $1.3M5 Dec 31, 2022 | +106.2% |
| Operating-lease assets (leased space) | $372.0K9 Dec 31, 2022 | $571.0K9 Dec 31, 2021 | −34.9% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $781.0K5 Dec 31, 2022 | $781.0K5 Dec 31, 2021 | 0% |
| Intangible assets, net (excluding goodwill) | $1.3M5 Dec 31, 2022 | $1.3M5 Dec 31, 2021 | −2.4% |
| Finite-lived intangibles, gross | $1.2M9 Dec 31, 2022 | $1.3M9 Dec 31, 2021 | −6.9% |
| Accumulated amortization | $1.1M9 Dec 31, 2022 | $1.1M9 Dec 31, 2021 | −5.1% |
| Finite-lived intangibles, net | $143.0K9 Dec 31, 2022 | $175.0K9 Dec 31, 2021 | −18.3% |
Inventory
Leadership
Who has led ThermoGenesis Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerRobin C. Stracey Jun 11, 2015 to Jul 28, 201615
- Chief executive officerMatthew T. Plavan Jan 16, 2009 to Sep 4, 201516
- Chief executive officerJ. Melville Engle Apr 24, 2009 to Aug 2, 201117
- Chief executive officerWilliam R. Osgood Aug 3, 2007 to Nov 12, 200818
- Chief executive officerPhilip H. Coelho May 15, 2006 to Apr 30, 200719
- ChairJ. Melville Engle Feb 17, 2011 to Aug 2, 201120
- PresidentKenneth Harris Feb 28, 2014 to Feb 20, 201521
- PresidentKevin Simpson Mar 15, 2006 to Mar 15, 200622
- Chief financial officerJeffery Cauble Jun 8, 2020 to Jun 1, 202123
- Chief financial officerMichael Bruch May 14, 2015 to Jul 28, 201624
- Chief financial officerDan T. Bessey Apr 1, 2013 to Dec 5, 201425
- Chief financial officerMatthew T. Plavan Apr 30, 2007 to Aug 2, 201126
- Chief operating officerVivian H. Liu Feb 28, 2017 to Jan 3, 201827
- Chief operating officerMatthew T. Plavan Aug 3, 2009 to Jun 14, 201028
- Chief operating officerKevin Simpson Mar 15, 2006 to Mar 15, 200622
Board members and other officers (38)
- Principal Accounting OfficerJeffery Cauble Mar 15, 2017 to Dec 18, 201829
- VP, ManufacturingKimberly Kay Ellner Mar 17, 2016 to Mar 30, 201730
- Vice PresidentKevin Cooksy Feb 8, 2012 to Feb 8, 201231
- VP, Scientific AffairsKaren Auditore Hargreaves Oct 12, 2011 to Nov 1, 201132
- VP, Engineering/ManufacturingKenneth Pappa Oct 19, 2011 to Apr 15, 201533
- Vice President of SalesHarold Baker Aug 13, 2009 to Mar 5, 201434
- VP, Quality/Regulatory AffairsJorge Artiles Oct 23, 2009 to Aug 2, 201135
- VP Quality/Regulatory AffairsLeslie Schnoll Jun 16, 2008 to Feb 3, 200936
- VP, MarketingJohn Groat Jul 15, 2008 to Feb 3, 200937
- VP, SalesSandra Lacava Jul 22, 2008 to Feb 3, 200938
- VP, R&DMenachem Shavit Aug 22, 2008 to Feb 17, 201139
- General Manager of OperationsWilliam R. Osgood Jan 5, 2007 to Jan 5, 200740
- VP Sales & MarketingDaniel Segal Feb 22, 2007 to Mar 2, 200741
- Chief Technology ArchitectPhilip H. Coelho Jul 31, 2007 to Jul 31, 200742
- VP of Scientific AffairsJohn Chapman Mar 16, 2006 to Aug 3, 200943
- Board memberBiao Xi Jul 24, 2023 to Jul 24, 202344
- Board memberHaihong Zhu Jan 27, 2022 to Jan 27, 202245
- Board memberDebra Donaghy Jan 9, 2020 to Jun 8, 202046
- Board memberThomis Joseph Jan 20, 2017 to Jun 8, 202047
- Board memberRussell M. Medford Mar 6, 2017 to Jun 8, 202048
- Board memberMark Westgate May 16, 2017 to Jun 8, 202049
- Board memberMark Bagnall Jul 1, 2016 to Jul 5, 201650
- Board memberVivian H. Liu Nov 16, 2016 to Jun 27, 202251
- Board memberKenneth Harris Feb 28, 2014 to Feb 20, 201521
- Board memberDenis Michael Rhein Dec 10, 2014 to Jul 6, 201652
- Board memberMatthew T. Plavan Aug 1, 2012 to Apr 17, 201553
- Board memberRobin C. Stracey Aug 9, 2011 to Jul 28, 201654
- Board memberJ. Melville Engle Sep 28, 2009 to Nov 2, 201055
- Board memberCraig W. Moore Dec 17, 2009 to Jul 6, 201656
- Board memberMahendra S. Rao Mar 18, 2008 to May 12, 201757
- Board memberTiffany Olson Aug 11, 2008 to Jan 13, 200958
- Board memberWilliam R. Osgood Aug 3, 2007 to Nov 12, 200818
- Board memberKevin Simpson Mar 15, 2006 to Mar 15, 200622
- Board memberGeorge J. Barry May 15, 2006 to Jul 3, 200759
- Board memberHubert E. Huckel Md. May 15, 2006 to Jul 1, 201160
- Board memberPhilip H. Coelho May 15, 2006 to Jul 31, 200719
- Board memberWoodrow A. Myers Jr. Jun 9, 2006 to Jul 6, 200961
- Board memberPatrick J. McEnany Jul 12, 2006 to Jul 2, 201462
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
Timeline
- Jan 6, 20258-K Entered a material agreement64
- Aug 6, 20248-K Change of auditor65
- Jul 16, 20248-K Other events66
- Jul 16, 20248-K Executive or director change67
- Jul 11, 20248-K Debt or obligation accelerated68
- Jul 2, 20248-K Other events69
- Jun 26, 20248-K Executive or director change70
- Jun 11, 20248-K Listing notice or transfer71
- Jun 4, 20248-K Other events72
- Apr 24, 20248-K Listing notice or transfer73
- Mar 20, 20248-K Other events74
- Mar 12, 20248-K Executive or director change75
- Jun 11, 2015New chief executive Robin C. Stracey becomes CEO15
- Apr 24, 2009New chief executive J. Melville Engle becomes CEO17
- Jan 16, 2009New chief executive Matthew T. Plavan becomes CEO16
- Aug 3, 2007New chief executive William R. Osgood becomes CEO18
- May 15, 2006New chief executive Philip H. Coelho becomes CEO19
- Jul 3, 1986Founded ThermoGenesis Holdings, Inc. is founded2
Calendar
When it reported results
- Nov 13, 2023Reported quarterly or annual results76
- Aug 10, 2023Reported quarterly or annual results77
- May 15, 2023Reported quarterly or annual results78
- Mar 30, 2023Reported quarterly or annual results79
- Nov 10, 2022Reported quarterly or annual results80
- Aug 11, 2022Reported quarterly or annual results81
- May 19, 2022Reported quarterly or annual results82
- Mar 28, 2022Reported quarterly or annual results83
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
124 filings to the SEC since October 2021: 4 annual reports, 8 quarterly reports, 53 major events, 9 insider forms, 8 large holders, 1 private raises, 41 other. The latest 20:
- Jan 6, 20258-K EDGAR
- Aug 15, 2024NT 10-Q EDGAR
- Aug 6, 20248-K EDGAR
- Jul 16, 20248-K EDGAR
- Jul 16, 20248-K EDGAR
- Jul 11, 20248-K EDGAR
- Jul 9, 20244 EDGAR
- Jul 2, 20248-K EDGAR
- Jun 28, 202425-NSE EDGAR
- Jun 26, 20248-K EDGAR
- Jun 11, 20248-K EDGAR
- Jun 4, 20248-K EDGAR
- May 17, 202410-Q EDGAR
- May 16, 2024NT 10-Q EDGAR
- Apr 24, 20248-K EDGAR
- Apr 16, 202410-K EDGAR
- Apr 2, 2024NT 10-K EDGAR
- Mar 20, 20248-K EDGAR
- Mar 19, 20244 EDGAR
- Mar 12, 20248-K EDGAR
The 124 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2023 | Xu XiaochunCEO | Sale | 600,000 | $1.02 | $612.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Boyalife Group, Inc.SC 13D/A, 4 filings Nov 9, 2022 to Nov 28, 202384
- Xiaochun XuSC 13D/A, 1 filing Mar 9, 202385
- FOLEY & LARDNER/ FASC 13D/A, 1 filing Feb 16, 202386
- Boyalife Asset Holding II, Inc.SC 13D/A, 2 filings Jul 12, 2022 to Aug 5, 202287
Money raised
Private offerings the company reported to the SEC on Form D.
- Mar 20, 2023Raised $3 million in a private offering of equity Form D: 1 investor so far Form D
SEC filer profile
How ThermoGenesis Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARThermoGenesis Holdings, Inc.1
- CIK0000811212
- Employer ID (EIN)94-30184871
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)3821 Laboratory Apparatus & Furniture1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address2890 Kilgore Rd., Rancho Cordova, CA 956701
- Phone91685851001
- Shares outstanding7,952,780 as of May 13, 202414
- Public float$2.8M as of Jun 30, 20235
- On EDGAR sinceOct 30, 19951
- Filings1,218 in all: 8-K (333), 4 (315), 10-Q (83), 3 (53), DEF 14A (32), 10-K (26), 424B3 (26), SC 13G (24)1
All 56 form types
S-3 (21), CORRESP (20), SC 13G/A (19), 425 (18), EFFECT (17), UPLOAD (17), DEFA14A (16), PRE 14A (15), S-8 (14), SC 13D/A (13), 424B5 (11), 10-K/A (10), 4/A (10), 5 (10), CT ORDER (10), 8-K/A (8), S-1/A (8), S-3/A (8), SC 13D (8), NT 10-Q (7), SD (6), 424B1 (5), 424B2 (5), D (5), 10KSB/A (4), PRER14A (4), S-1 (4), 10-Q/A (3), 10QSB (3), REGDEX (3), S-4/A (3), 10QSB/A (2), 424B4 (2), ARS (2), POS AM (2), 10-K405 (1), 10-KT (1), 10KSB (1), 10KSB40/A (1), 25-NSE (1), 3/A (1), DEFR14A (1), FWP (1), NT 10-K (1), POS EX (1), RW (1), S-1MEF (1), S-4 (1)
- Latest filingsAnnual report (10-K) Apr 16, 2024
Quarterly report (10-Q) May 17, 2024
Proxy statement (DEF 14A) Oct 26, 2023
Latest 8-K (8-K) Jan 6, 2025
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARJ. Melville Engle, Chair
- 21SEC EDGARKenneth Harris, President
- 22SEC EDGARKevin Simpson, President
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARKevin Cooksy, Vice President
- 32
- 33
- 34
- 35
- 36
- 37SEC EDGARJohn Groat, VP, Marketing
- 38SEC EDGARSandra Lacava, VP, Sales
- 39SEC EDGARMenachem Shavit, VP, R&D
- 40
- 41SEC EDGARDaniel Segal, VP Sales & Marketing
- 42
- 43
- 44SEC EDGARBiao Xi, Board member
- 45SEC EDGARHaihong Zhu, Board member
- 46SEC EDGARDebra Donaghy, Board member
- 47SEC EDGARThomis Joseph, Board member
- 48SEC EDGARRussell M. Medford, Board member
- 49SEC EDGARMark Westgate, Board member
- 50SEC EDGARMark Bagnall, Board member
- 51SEC EDGARVivian H. Liu, Board member
- 52SEC EDGARDenis Michael Rhein, Board member
- 53SEC EDGARMatthew T. Plavan, Board member
- 54SEC EDGARRobin C. Stracey, Board member
- 55SEC EDGARJ. Melville Engle, Board member
- 56SEC EDGARCraig W. Moore, Board member
- 57SEC EDGARMahendra S. Rao, Board member
- 58SEC EDGARTiffany Olson, Board member
- 59SEC EDGARGeorge J. Barry, Board member
- 60SEC EDGARHubert E. Huckel Md., Board member
- 61SEC EDGARWoodrow A. Myers Jr., Board member
- 62SEC EDGARPatrick J. McEnany, Board member
- 63
- 64SEC EDGAREntered a material agreement
- 65SEC EDGARChange of auditor
- 66SEC EDGAROther events
- 67SEC EDGARExecutive or director change
- 68SEC EDGARDebt or obligation accelerated
- 69SEC EDGAROther events
- 70SEC EDGARExecutive or director change
- 71SEC EDGARListing notice or transfer
- 72SEC EDGAROther events
- 73SEC EDGARListing notice or transfer
- 74SEC EDGAROther events
- 75SEC EDGARExecutive or director change
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87